Filing Details

Accession Number:
0001140361-17-029589
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-01 16:19:52
Reporting Period:
2017-08-01
Filing Date:
2017-08-01
Accepted Time:
2017-08-01 16:19:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1656328 Sienna Biopharmaceuticals Inc. SNNA Pharmaceutical Preparations (2834) 273364627
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1711464 K. Timothy Andrews C/O Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road, Suite 140
Westlake Village CA 91362
General Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-08-01 15,000 $15.00 15,000 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 51,737 Direct
Footnotes
  1. The Reporting Person purchased the shares of the Issuer's common stock in connection with the Issuer's initial public offering at the offering price of $15.00 per share.
  2. The shares are directly held by Steelhead Bioventures LLC, a limited liability company in which the Reporting Person holds a controlling interest.